Area of research
Immunology · Oncology
Research interest
Research focused on Glioblastoma and Vaccination, with related work in Cancer, Messenger RNA, Immunotherapy. Notable publications include 'Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer', 'Actively personalized vaccination trial for newly diagnosed glioblastoma', and 'Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening'.
TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trial
Abstract CT202: IVAC MUTANOME: Individualized vaccines for the treatment of cancer
NF‐κB factors control the induction of NFATc1 in B lymphocytes